The stem cell panel market is likely to register a CAGR of 10.4% during the forecast period. The value of the global market was US$ 9.84 Bn in 2021 and is expected to reach US$ 29.81 Bn by 2032.
| Attributes | Details |
| CAGR | 10.4% |
| Value (2021) | 9.84 Bn |
| Value (2032) | 29.81 Bn |
Lately, the advancements of developmental biology have opened new ways for the analysis and discovery of stem cells and the use of embryonic stem cells and mesenchymal stem cells, increasing the sales of stem cell panels.
Another use of it is in determining the self-renewal and differentiation process of stem cells. It also provides more multipotent, pluripotent and totipotency status.
The panel includes a collection of various antibodies, which are undifferentiated embryonic stem cells. It provides and allows prolonged access to determine various stem cells.
This excessive growth in the demand for stem cell panels. The increased sales of stem cell panels are also driven by the awareness around the government initiatives spreading the word about the stem cell panel market.
Rapidly increasing list of chronic diseases which require novel approaches for their treatment. The need for finding a cure for Hematopoietic and genetic disorders has given rise to the growth of research in stem cells and hence enhancing the demand for stem cell panel.
The introduction of new approaches to the isolation and harvesting procedures of stem cells has led to an increase in demand for stem cell panels.
The major drivers of the stem cell panel market are the consolidation of health insurance firms with speciality clinics. This merger has made stem cell therapy approachable to a wide area of patients as they allow the patients to acquire stem cell therapy reimbursement. These small factors push the sales of stem cell panel.
Recent advances in stem cell therapy such as stem cell-mediated suicide gene therapy for curing cancer, stem cells used as driver vehicles for oncolytic virus and so on is, creating demand in the stem cell market.
North America and Europe are areas in which stem cell research is abundant. They contribute largely to the stem cell panel market.
The United Kingdom has been a recognized member of the stem cell panel market. These regions can be Japan is also one of the nations involved in the research of stem cells.
Singapore is a known nation in Asian countries carrying out studies utilizing stem cell panels. These areas are expected to be on top of the list for involving new technological advancements.
These regions are expected to dominate the demand for stem cell panels. The Middle East and Africa are also progressing towards stem cells and are participating in the Stem cell panel market.
The key players of stem cell panel market are focusing on enhancing and adopting stategies like mergers, novel product launch and acquisitions to foster business . This is driving the sales of Stem cell panels.
Key players in stem cell panel market include, R&D systems Inc., Thermo Fisher Scientific, Abcam plc, BD Biosciences, Creative Bioarray, STEM CELL Technologies Inc., Evercyte GmbH, Illumina Inc., BioLegend Inc., Quest Diagnostics Inc. and others
| Report Attribute | Details |
| Growth Rate | CAGR of 4.8% from 2022 to 2032 |
| Base year for estimation | 2021 |
| Historical data | 2015 – 2020 |
| Forecast period | 2022 – 2032 |
| Quantitative units | Revenue in USD billion, volume in kilotons, and CAGR from 2022 to 2032 |
| Report coverage | Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis, |
| Segments covered | Application, End User, Region |
| Regional scope | North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia and New Zealand |
| Country scope | U.S.; Canada; Mexico; Germany; U.K.; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; UAE; Iran; South Africa |
| Key companies profiled | R&D systems Inc, Thermo Fisher Scientific, Abcam plc, BD Biosciences, Creative bioarray, STEM CELL Technologies Inc, Evercyte GmbH, Illumina Inc, BioLegend Inc and Quest Diagnostics Inc |
| Customization scope | Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. |
North America is the biggest segment in the stem cell panel market and is expected to hold a big portion of the market in the forecast period. This leads to the high demand for stem cell panels in developed countries.
Key competitors holding substantial stem cell panel market share include R& D systems Inc., Thermo fisher scientific, Abcam plc, BD Biosciences, Creative bioarray, STEM CELL technologies Inc., Evercyte GmbH, Illumina Inc., BioLegend Inc. and Quest Diagnostics Inc etc.
Demand for Stem cell panel is likely to rise with the increased use of stem cells in multiple chronic diseases like cancer etc. That is going to increase the sales of stem cell panel.
Explore Similar Insights
Stem Cell Panel Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
